Strange, Poul

Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects

Mudaliar, S. R., Lindberg, F. A., Joyce, M., Beerdsen, P., Strange, P., Lin, A., & Henry, R. R. (1999) · Diabetes Care

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 276

Impact of Active Versus Usual Algorithmic Titration of Basal Insulin and Point-of-Care Versus Laboratory Measurement of HbA1c on Glycemic Control in Patients With Type 2 Diabetes

Kennedy, L., Herman, W. H., Strange, P., Harris, A., & for the GOAL A1C Team (2006) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 189

Does Glycemic Variability Impact Mood and Quality of Life?

Penckofer, S., Quinn, L., Byrn, M., Ferrans, C., Miller, M., & Strange, P. (2012) · Diabetes Technology & Therapeutics

Diabetes Management and ResearchDiabetes Management and Education

Cited by 138

Insulin 70/30 Mix Plus Metformin Versus Triple Oral Therapy in the Treatment of Type 2 Diabetes After Failure of Two Oral Drugs

Schwartz, S., Sievers, R., Strange, P., Lyness, W. H., Hollander, P., & For The INS-2061 Study Team (2003) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 117

Effectiveness of V-Go(®) for patients with type 2 diabetes in a real-world setting: A prospective observational study

Grunberger, G., Rosenfeld, C. R., Bode, B. W., Abbott, S. D., Nikkel, C., Shi, L., & Strange, P. (2020) · Drugs - Real World Outcomes

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 19